Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $45.3461 (-2.29%) ($45.2467 - $46.2220) on Mon. Jun. 9, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.72% (three month average) | RSI | 48 | Latest Price | $45.3461(-2.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) SPY(47%) VT(44%) XBI(41%) QQQ(40%) | Factors Impacting ABBV price | ABBV will decline at least -0.86% in a week (0% probabilities). VIXM(-25%) TLT(-15%) UUP(-7%) GLD(-5%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.86% (StdDev 1.72%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $46.02(-1.46%) | 10 Day Moving Average | $45.81(-1.01%) | 20 Day Moving Average | $45.32(0.06%) | To recent high | -2.6% | To recent low | 15.9% | Market Cap | $80.003b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |